Table 1.
Study characteristics of the included research for MMG
| Author | Year of publication | Country | Patients/lesions (n) | Mean age (range) | Imaging modalities | Study design | TP | FP | FN | TN |
|---|---|---|---|---|---|---|---|---|---|---|
| Ying | 2012 | China | 549/665 | 46 (12–92) | MMG | Retrospective | 201 | 61 | 45 | 358 |
| Wu | 2016 | China | 312 | 49 (27–85) | MMG | Prospective | 77 | 9 | 41 | 185 |
| Shao | 2013 | China | 90/90 | 53.2 ± 7.6 | MMG | Prospective | 40 | 13 | 15 | 22 |
| Mello | 2017 | Brazil | 664 | NA | MMG | Retrospective | 83 | 44 | 9 | 528 |
| Berg | 2012 | USA | 4814 | NA | MMG | Retrospective | 57 | 414 | 18 | 4325 |
| Habib | 2009 | Pakistan | 20 | 36.5 [17–80] | MMG | Retrospective | 11 | 4 | 1 | 4 |
| Lehman | 2012 | USA | 954/1208 | 35 [30–39] | MMG | Retrospective | 14 | 66 | 9 | 1119 |
| Zahid | 2009 | Pakistan | 210 | 35–60 | MMG | Retrospective | 40 | 6 | 12 | 152 |
| Yu | 2016 | China | 287 | 48.2 (32–75) | MMG | Retrospective | 127 | 40 | 41 | 79 |
| Ozulker | 2010 | Turkey | 46/29 | NA | MMG | Prospectively | 13 | 5 | 3 | 8 |
| Omranipour | 2016 | Iran | 132 | 49.5 ± 10.3 | MMG | Prospectively | 70 | 12 | 17 | 33 |
| Meissnitzer | 2015 | Austria | 67/92 | > 50 | MMG | Prospective | 57 | 18 | 10 | 7 |
| Tan | 2014 | China | 326 | 40–60 | MMG | Retrospective | 36 | 28 | 38 | 224 |
| Cho | 2016 | Korea | 162 | NA | MMG | Retrospective | 49 | 42 | 17 | 54 |
| Lee | 2012 | Korea | 107/474 | 49.63 ± 10.43 | MMG | Retrospective | 103 | 34 | 7 | 330 |
| Zhao | 2015 | China | 274 | NA | MMG | Retrospective | 117 | 37 | 15 | 105 |
| Park | 2014 | Korea | 114/118 | 49.6 ± 9.8 | MMG | Retrospective | 24 | 14 | 18 | 62 |
| Yao | 2014 | China | 2036 | > 35 | MMG | Retrospective | 374 | 27 | 104 | 1529 |
| Novikov | 2017 | Austria | 367 | NA | MMG | Prospective | 346 | 19 | 21 | 51 |
NA not assigned, MMG mammograpgy